{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:11:16Z","timestamp":1787508676858,"version":"build-2736575974"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007214","name":"Velux Foundation","doi-asserted-by":"publisher","award":["25723"],"award-info":[{"award-number":["25723"]}],"id":[{"id":"10.13039\/100007214","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase and Ejnar Danielsen Foundation","doi-asserted-by":"publisher","award":["18-10-0473"],"award-info":[{"award-number":["18-10-0473"]}],"id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Odense University Hospital Internationalization Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Denosumab is an anti-resorptive therapy that effectively reduces fracture risk and increases BMD in women with postmenopausal osteoporosis. In this study, we focused on the less well-investigated cortical remodeling process and its transition from erosion to formation after denosumab treatment, using a histomorphometric classification of intracortical pores. Cortical bone is more prominent in non-vertebral bones, where denosumab is less effective in fracture reduction. In iliac crest biopsies from the FREEDOM-study, where postmenopausal osteoporotic women were treated with placebo (n\u2009=\u200943) or denosumab (n\u2009=\u200943) for 2-3\u00a0yr, the cortical microstructure and remodeling stage and type of intracortical pores were analyzed. Cortical thickness was unaffected in the denosumab group vs placebo (P\u2009=\u2009.9). Mean pore diameter was significantly decreased in the denosumab group vs placebo (P\u2009&amp;lt;\u2009.002) with no change in the number of pores per tissue area (P\u2009=\u2009.83). However, the cortical porosity was not decreased in the denosumab vs placebo group (P\u2009&amp;lt;\u2009.077). When stratifying the pores according to their remodeling stage, the eroded pores had an increased contribution to the total pore area in the denosumab vs placebo group (P\u2009=\u2009.001). Eroded-formative and formative pores had a decreased contribution to the total pore area (P\u2009&amp;lt;\u2009.001). The contribution of quiescent pores was unchanged. The increased contribution of eroded pores and the concomitant reduced contribution of eroded-formative and formative pores indicate that the transition from erosion to formation is largely limited, while pores with ongoing bone formation at the time of initiation of denosumab treatment are refilled.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziaf181","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:16:38Z","timestamp":1763558198000},"source":"Crossref","is-referenced-by-count":1,"title":["Denosumab treatment of osteoporotic women arrests cortical bone remodeling events at the reversal-resorption phase but does not affect ongoing bone formation"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4922-2478","authenticated-orcid":false,"given":"Xenia Goldberg","family":"Dahl","sequence":"first","affiliation":[{"name":"Molecular Bone Histology Team, Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark , 5230 Odense M ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Roux","sequence":"additional","affiliation":[{"name":"Univ Lyon, INSERM, UMR 1033, UFR de M\u00e9decine Lyon-Est , F-69008 Lyon ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Delaisse","sequence":"additional","affiliation":[{"name":"Molecular Bone Histology Team, Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark , 5230 Odense M ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Huang","sequence":"additional","affiliation":[{"name":"Center for Design and Analysis, Amgen Inc. , Thousand Oaks, CA 91320 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5128-7361","authenticated-orcid":false,"given":"Pascale","family":"Chavassieux","sequence":"additional","affiliation":[{"name":"Univ Lyon, INSERM, UMR 1033, UFR de M\u00e9decine Lyon-Est , F-69008 Lyon ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-5677","authenticated-orcid":false,"given":"Christina M","family":"Andreasen","sequence":"additional","affiliation":[{"name":"Molecular Bone Histology Team, Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark , 5230 Odense M ,","place":["Denmark"]},{"name":"Department of Pathology, Odense University Hospital , 5000 Odense ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L","family":"Andersen","sequence":"additional","affiliation":[{"name":"Molecular Bone Histology Team, Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark , 5230 Odense M ,","place":["Denmark"]},{"name":"Department of Pathology, Odense University Hospital , 5000 Odense ,","place":["Denmark"]},{"name":"Department of Forensic Medicine, Aarhus University , 8200 Aarhus N ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"issue":"1","key":"2026011009471230400_ref1","doi-asserted-by":"publisher","first-page":"16069","DOI":"10.1038\/nrdp.2016.69","article-title":"Postmenopausal osteoporosis","volume":"2","author":"Eastell","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"June","key":"2026011009471230400_ref2","doi-asserted-by":"publisher","first-page":"115516","DOI":"10.1016\/j.bone.2020.115516","article-title":"Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: combined and sequential approaches","volume":"139","author":"Langdahl","year":"2020","journal-title":"Bone."},{"issue":"1","key":"2026011009471230400_ref3","doi-asserted-by":"publisher","first-page":"10892","DOI":"10.1038\/s41598-023-37944-x","article-title":"Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system","volume":"13","author":"Xiao","year":"2023","journal-title":"Sci Rep"},{"issue":"5","key":"2026011009471230400_ref4","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2019-00192","article-title":"Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis","volume":"104","author":"Barrionuevo","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026011009471230400_ref5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF03187471","article-title":"Age-related changes in resorption cavity characteristics in human trabecular bone","volume":"1","author":"Croucher","year":"1991","journal-title":"Osteoporos Int"},{"issue":"1","key":"2026011009471230400_ref6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ajpath.2013.03.006","article-title":"Understanding coupling between bone resorption and formation: are reversal cells the missing link?","volume":"183","author":"Andersen","year":"2013","journal-title":"Am J Pathol"},{"key":"2026011009471230400_ref7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bone.2018.09.011","article-title":"Understanding age-induced cortical porosity in women: is a negative BMU balance in quiescent osteons a major contributor?","volume":"117","author":"Andreasen","year":"2018","journal-title":"Bone"},{"issue":"7","key":"2026011009471230400_ref8","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/jbmr.3169","article-title":"Tethering formation to resorption: reversal revisited","volume":"32","author":"Dempster","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2026011009471230400_ref9","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/jbmr.3091","article-title":"Coupling of bone resorption and formation in real time: new knowledge gained from human havervians BMUs","volume":"32","author":"Lassen","year":"2017","journal-title":"J Bone Miner Res"},{"key":"2026011009471230400_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115628","volume-title":"Re-Thinking the Bone Remodeling Cycle Mechanism and the Origin of Bone Loss","author":"Delaisse","year":"2020"},{"issue":"24","key":"2026011009471230400_ref11","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA J Am Med Assoc"},{"issue":"1","key":"2026011009471230400_ref12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1359\/jbmr.0809010","article-title":"Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial","volume":"24","author":"Brown","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2026011009471230400_ref13","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/jbmr.81","article-title":"Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate","volume":"25","author":"Seeman","year":"2010","journal-title":"J Bone Miner Res"},{"key":"2026011009471230400_ref14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/01.ogx.0000219511.20627.d3","volume-title":"Denosumab in Postmenopausal Women with Low Bone Mineral Density Abstract","author":"McClung","year":"2006"},{"issue":"10","key":"2026011009471230400_ref15","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/jbmr.2855","article-title":"Denosumab reduces cortical porosity of the proximal femoral shaft in postmenopausal women with osteoporosis","volume":"31","author":"Zebaze","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2026011009471230400_ref16","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1002\/jbmr.149","article-title":"Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies","volume":"25","author":"Reid","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026011009471230400_ref17","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/jbmr.3631","article-title":"Reduction of cortical bone turnover and erosion depth after 2 and 3 years of denosumab: iliac bone histomorphometry in the FREEDOM trial","volume":"34","author":"Chavassieux","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2026011009471230400_ref18","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/jbmr.2480","article-title":"Sustained modeling-based bone formation during adulthood in cynomolgus monkeys may contribute to continuous BMD gains with denosumab","volume":"30","author":"Ominsky","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2026011009471230400_ref19","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/jbmr.4006","article-title":"Modeling-based bone formation in the human femoral neck in subjects treated with denosumab","volume":"35","author":"Dempster","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026011009471230400_ref20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/jbmr.3354","article-title":"Understanding age-induced cortical porosity in women: the accumulation and coalescence of eroded cavities upon existing intracortical canals is the main contributor","volume":"33","author":"Andreasen","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2026011009471230400_ref21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"2026011009471230400_ref22","doi-asserted-by":"publisher","journal-title":"Osteoporotic Fracture and Systemic Skeletal Disorders","DOI":"10.1007\/978-981-16-5613-2_7"},{"issue":"59","key":"2026011009471230400_ref23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bone.2013.11.016","article-title":"Differing effects of denosumab and alendronate on cortical and trabecular bone","volume":"59","author":"Zebaze","year":"2014","journal-title":"Bone."},{"issue":"5","key":"2026011009471230400_ref24","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1210\/jc.2016-1160","article-title":"Effects of two years of teriparatide, denosumab, or both on bone microarchitecture and strength (DATA-HRpQCT study)","volume":"101","author":"Tsai","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026011009471230400_ref25","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00198-018-4624-4","article-title":"Effects of osteoporosis drug treatments on cortical and trabecular bone in the femur using DXA-based 3D modeling","volume":"29","author":"Winzenrieth","year":"2018","journal-title":"Osteoporos Int"},{"key":"2026011009471230400_ref26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.bonr.2017.11.002","article-title":"Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosis","volume":"7","author":"Sone","year":"2017","journal-title":"Bone Rep"},{"issue":"7","key":"2026011009471230400_ref27","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s40618-023-02280-4","article-title":"Differential effects of teriparatide, denosumab and zoledronate on hip structural and mechanical parameters in osteoporosis; a real-life study","volume":"47","author":"Jaarah","year":"2024","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"2026011009471230400_ref28","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1118\/1.3689813","article-title":"The effect of voxel size on high-resolution peripheral computed tomography measurements of trabecular and cortical bone microstructure","volume":"39","author":"Tjong","year":"2012","journal-title":"Med Phys"},{"issue":"7","key":"2026011009471230400_ref29","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2026011009471230400_ref30","doi-asserted-by":"publisher","first-page":"116896","DOI":"10.1016\/j.bone.2023.116896","article-title":"Osteoprogenitor recruitment and differentiation during intracortical bone remodeling of adolescent humans","volume":"177","author":"van Dijk","year":"2023","journal-title":"Bone"},{"issue":"8","key":"2026011009471230400_ref31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.molmed.2014.06.001","article-title":"Osteoclasts: more than \u2018bone eaters\u2019","volume":"20","author":"Charles","year":"2014","journal-title":"Trends Mol Med"},{"issue":"10","key":"2026011009471230400_ref32","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/jbmr\/zjae110","article-title":"Osteoclast-derived coupling factors: origins and state-of-play Louis V Avioli Lecture, ASBMR 2023","volume":"39","author":"Sims","year":"2024","journal-title":"J Bone Miner Res"},{"key":"2026011009471230400_ref33","doi-asserted-by":"publisher","first-page":"896841","DOI":"10.3389\/fmolb.2022.896841","article-title":"Spatial organization of osteoclastic coupling factors and their receptors at human bone remodeling sites","volume":"9","author":"Borggaard","year":"2022","journal-title":"Front Mol Biosci"},{"key":"2026011009471230400_ref34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-14003-6","article-title":"Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism","volume":"11","author":"Weivoda","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"2026011009471230400_ref35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bone.2011.02.011","article-title":"Bisphosphonates for postmenopausal osteoporosis","volume":"49","author":"Eastell","year":"2011","journal-title":"Bone"},{"issue":"12","key":"2026011009471230400_ref36","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00198-015-3234-7","article-title":"The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study","volume":"26","author":"Papapoulos","year":"2015","journal-title":"Osteoporos Int"},{"issue":"1","key":"2026011009471230400_ref37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41413-024-00362-4","article-title":"Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect","volume":"12","author":"El-Masri","year":"2024","journal-title":"Bone Res"},{"key":"2026011009471230400_ref38","doi-asserted-by":"publisher","first-page":"116419","DOI":"10.1016\/j.bone.2022.116419","article-title":"Alendronate prolongs the reversal-resorption phase in human cortical bone remodeling","volume":"160","author":"Borggaard","year":"2022","journal-title":"Bone"},{"issue":"May","key":"2026011009471230400_ref39","doi-asserted-by":"publisher","first-page":"101091","DOI":"10.1016\/j.bonr.2021.101091","article-title":"Disturbance of osteonal bone remodeling and high tensile stresses on the lateral cortex in atypical femoral fracture after long-term treatment with risedronate and alfacalcidol for osteoporosis","volume":"14","author":"Hirano","year":"2021","journal-title":"Bone Rep"},{"issue":"13","key":"2026011009471230400_ref40","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMc1107029","article-title":"Atypical femoral fractures and bone turnover","volume":"365","author":"Jamal","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"2026011009471230400_ref41","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2026011009471230400_ref42","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1210\/jc.2017-02669","article-title":"Effects of long-term denosumab on bone histomorphometry and mineralization in women with postmenopausal osteoporosis","volume":"103","author":"Dempster","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026011009471230400_ref43","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/jbmr.251","article-title":"Effects of denosumab on bone turnover markers in postmenopausal osteoporosis","volume":"26","author":"Eastell","year":"2011","journal-title":"J Bone Miner Res"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziaf181\/65467010\/ziaf181.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/1\/ziaf181\/65467010\/ziaf181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/10\/1\/ziaf181\/65467010\/ziaf181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T14:47:17Z","timestamp":1768056437000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziaf181\/8340144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziaf181","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,11,22]]},"article-number":"ziaf181"}}